Jacob Asset Management of New York’s DexCom DXCM Stock Holding History

Jacob Asset Management of New York’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	$423K	Buy	+60,000	New	+$380K	0.52%	56

Other funds holding DXCM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

TCP

TAMRO Capital Partners Alexandria, Virginia $369M AUM 1.2% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Jacob Asset Management of New York's DXCM Position: Q3 2013 in Review

Jacob Asset Management of New York opened a new position in DexCom (DXCM) in Q3 2013: 60,000 shares worth $423K. The stake represents 0.52% of the portfolio and ranks #56 among its holdings.

175 funds tracked by Wall St. Rank hold DXCM as of Q3 2013.

Jacob Asset Management of New York held 60,000 shares of DexCom worth $423K as of Q3 2013.
DexCom was a new Jacob Asset Management of New York position in Q3 2013.
DexCom made up 0.52% of Jacob Asset Management of New York's portfolio in Q3 2013, its #56 holding.
175 funds tracked by Wall St. Rank held DexCom as of Q3 2013.

Based on Jacob Asset Management of New York's 13F filing for Q3 2013, filed 14 Nov 2013.